How do I encourage clinicians to transfuse mismatched blood to patients with autoimmune hemolytic anemia in urgent situations?


  • The author is a consultant and a member of the Board of Directors of Northfield Laboratories, a company attempting to make blood substitutes.

Paul M. Ness MS, The Johns Hopkins Medical Institutions, 600 North Wolfe Street/Carnegie 667, Baltimore, MD 21287; e-mail: